Occupational risk for cytomegalovirus, but not for parvovirus B19 in child-care personnel in France

Journal of Infection

Volumn 63, Issue 6, 2011, Pages 457-467

  Billette de Villemeur, Agathe ^a,d   Gratacap Cavallier, Bénédicte ^a   Casey, Romain ^a   Baccard Longère, Monique ^b   Goirand, Laurence ^a   Seigneurin, Jean Marie ^b   Morand, Patrice ^b,c  

^a Service infections sexuellement transmissibles   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c CNRS   (France)

^d Rectorat de Grenoble   (France)

Author keywords

Child care staff; Cytomegalovirus; Epidemiology; Occupational hazard; Parvovirus B19; Rubella; Seroprevalence; Varicella

Indexed keywords

ADULT; ARTICLE; ATTRIBUTABLE RISK; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENVIRONMENTAL EXPOSURE; FEMALE; FRANCE; HEALTH CARE PERSONNEL; HERPES ZOSTER; HUMAN; HUMAN PARVOVIRUS B19; INFECTION RISK; MAJOR CLINICAL STUDY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; QUESTIONNAIRE; RUBELLA; SEROLOGY; SEROPREVALENCE; WOMEN'S HEALTH; WORK ENVIRONMENT;

ADULT; CHICKENPOX; CHILD CARE; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FRANCE; HEALTH PERSONNEL; HUMANS; INFANT; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; RISK; RISK ASSESSMENT; RUBELLA; SEROEPIDEMIOLOGIC STUDIES;

EID: 82255162824     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.06.012     Document Type: Article

References (51)

1. Gnann J.W. Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis 2002, 186(Suppl. 1):S91-S98.
2. Enders G., Miller E., Cradock-Watson J., Bolley I., Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994, 343:1548-1551.
3. Pastuzak A., Levy M., Schick B., Zuber C., Feldkamp M., Gladstone J., et al. Outcome after maternel varicella infection in the first 20 weeks of pregnancy. N Engl J Med 1994, 330:901-905.
4. Gyorkos T.W., Beliveau C., Rahme E., Muecke C., Joseph S., Soto J.C. High rubella seronegativity in daycare educators. Clin Invest Med 2005, 28:105-111.
5. Parent du Châtelet I., Bouraoui L. Rubella detected in pregnant women and newborns in France in 2004 and 2005: data from the Renarub laboratory network 2007, BEH, 20.
6. Crowcroft N., Pebody R. Prevention of congenital rubella infection: a challenge for every country in Europe. Euro Surveill 2004, 9:1-2.
7. Gratacos E., Torres P.J., Vidal J., Antolín E., Costa J., Jiménez de Anta M.T., et al. The incidence of human parvovirus B19 infection in pregnancy and its impact on perinatal outcome. J Infect Dis 1995, 171:1360-1363.
8. Kenenson A., Cannon M.J. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007, 17:253-276.
9. Stegmann B.J., Carey J.C. TORCH infections. Toxoplasmosis, other (syphilis, varicella-zoster, parvovirus B19), rubella, cytomegalovirus (CMV), and herpes infections. Curr Womens Health Rep 2002, (4):253-258.
10. Audibert F. Routine cytomegalovirus screening during pregnancy: is it worthwhile?. J Gynecol Obstet Biol Reprod 2003, 321(Suppl.: 1S50-5).
11. Ross S.A., Arora N., Novak Z., Fowler K.B., Britt W.J., Boppana S.B. Cytomegalovirus reinfections in healthy seroimmune women. J Infect Dis 2010, 1(201):386-389.
12. Parent Du Chatelet I. Survey on congenital CMV infections detected during pregnancy or at birth in metropolitan France. Collection Maladies infectieuses. Report 2007, Saint-Maurice; Institut de Veille Sanitaire, 12.
13. Jones S.E., Armstrong C.B., Bland C., Walter E.B., Clements D.A. Varicella prevalence in day care centers. Pediatr Infect Dis J 1995, 14:404-405.
14. Yawn B.P., Yawn R.A., Lydick E. Community impact of childhood varicella infections. J Pediatr 1997, 130:759-765.
15. Adler S.P., Manganello A.M., Koch W.C., Hempfling S.H., Best A.M. Risk of human parvovirus B19 infections among school and hospital employees during endemic periods. J Infect Dis 1993, 168:361-368.
16. Gillepsie S.M., Cartter M.L., Asch S. Occupational risk of human Parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. JAMA 1990, 263:2061-2065.
17. Gilbert N.L., Gyorkos T.W., Beliveau C., Rahme E., Muecke C., Soto J.C. Seroprevalence of parvovirus B19 infection in daycare educators. Epidemiol Infect 2005, 133:299-304.
18. Pass R.F., Hutto C., Lyon M.D., Cloud G. Increased rate of cytomegalovirus infection among daycare center workers. Pediatr Infect Dis J 1990, 9:465-470.
19. Adler S.P. Cytomegalovirus and child day care. Evidence for an increased infection rate among daycare workers. N Engl J Med 1989, 321:1290-1296.
20. Joseph S.A., Beliveau C., Muecke J., Rahme E., Soto J.C., Flowerdew G., et al. Risk factors for cytomegalovirus seropositivity in a population of day care educators in Montréal, Canada. Occup Med 2005, 55:564-567.
21. Ford-Jones L.E., Kitai I., Davis L., Corey M., Farrell H., Petric M., et al. Cytomegalovirus infections in Toronto child day centers: a prospective study of viral excretion in children and seroconversion among day-care providers. Pediatr Infect Dis J 1996, 15:507-514.
22. Ministère des Affaires Sociales, du Travail et de la Solidarité et le Ministère de la Santé, de la Famille et des Personnes Handicapées Avis du Conseil supérieur d'hygiène publique de France relative à la vaccination contre la varicelle. Séance du 19 mars 2004 2004, BEH, n°;28-29.
23. Levy-Bruhl D. The risks of a mismanaged immunization program: the example of vaccination against rubella. Rev. Epidém Sante Publ., Resp 2000, 48:309-310.
24. Ministère des Affaires Sociales, du Travail et de la Solidarité et le Ministère de la Santé, de la Famille et des Personnes Handicapées Avis du comité supérieur d'hygiène publique de France, section des maladies transmissibles relatif aux recommandations pour la prévention de l'infection à cytomégalovirus chez les femmes enceintes. Séance du 8 mars 2002.
25. Latapy C., Midy F. Assessment of screening for cytomegalovirus (CMV) infection in pregnant women in France. Saint-Denis La Plaine 2004, ANAES (French National Agency for Accreditation and Evaluation in Healthcare), France.
26. Gutierrez R. Re: st: discrepancy between logit and log links in glm [Internet]. Statalist 2004, Available at:. http://www.stata.com/statalist/archive/2004-07/msg00560.html.
27. Gutierrez R. Re: st: Binomial regression [Internet]. Statalist 2007, Available at:. http://www.stata.com/statalist/archive/2007-08/msg00177.html.
28. Barros A.J., Hirakata V.N. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 2003, 321.
29. Lumley T., Kronmal R., Ma S. Relative risk regression in medical research: models, contrasts, estimators, and algorithms. UW Biostatistics Working Paper Series 2006, Working Paper 29324.
30. McNutt L.A., Wu C., Xue X., Hafner J.P. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 2003, 157:940-943.
31. Skov T., Deddens J., Petersen M.R., Endahl L. Prevalence proportion ratios: estimation and hypothesis testing. Int J Epidemiol 1998, 27(1):91-95.
32. Blizzard L., Hosmer D.W. Parameter estimation and goodness-of-fit in log binomial regression. Biom J 2006, 48:5-22.
33. Stata programs. Available at:. http://www.homepages.ucl.ac.uk/%7Eucakgam/stata.html.
34. Rothman K.J., Greenland S., Thimothey L.L. Modern epidemiology 2008, Lippincott-Williams & Wilkins, Philadelphia, PA. 3rd ed.
35. Valeur-Jensen A.K., Pedersen C.B., Westergaard T., Jensen I.P., Lebech M., Andersen P.K., et al. Risk factors for parvovirus B19 infection in pregnancy. JAMA 1999, 281:1099-1105.
36. Cohen B.J., Buckley M.M. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 1988, 25:151-153.
37. Röhrer C., Gärtner B., Sauerbrei A., Böhm S., Hottenträger B., Raab U., et al. Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect 2008, 136:1564-1575.
38. Stelma F.F., Smismans A., Goossens V.J., Bruggeman C.A., Hoebe C.J. Occupational risk of human Cytomegalovirus and Parvovirus B19 infection in female day care personnel in the Netherlands; a study based on seroprevalence. CJ Eur J Clin Microbiol Infect Dis 2009, 28:393-397.
39. Kelly H.A., Siebert D., Hammond R., Leydon J., Kiely P., Maskill W. The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world. Epidemiol Infect 2000, 124:449-457.
40. Reinheimer C., Allwinn R., Doerr H.W., Wittek M. Seroepidemiology of parvovirus B19 in the Frankfurt am Main area, Germany: evaluation of risk factors. Infection 2010, 38:381-385.
41. Lamont R., Sobel J., Vaisbuch E., Kusanovic J.P., Mazaki-Tovi S., Kim S.K., et al. Parvovirus B19 infection in human pregnancy. BJOG 2011, 118:175-186.
42. Mossong J., Hens N., Friederichs V. Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection. Epidemiol Infect 2008, 136:1059-1068.
43. Gratacap-Cavallier B., Bosson J.L., Morand P., Dutertre N., Chanzy B., Jouk P.S., et al. Cytomégalovirus seroprevalence in French women: parity and place of birth as major predictive factors. Eur J Epidemiol 1998, 14:147-152.
44. Joseph S.A., Beliveau C., Muecke C.J., Rahme E., Soto J.C., Flowerdew G., et al. Cytomegalovirus as an occupational risk in daycare educators. Paediatr Child Health 2006, 11:401-407.
45. Bate S.L., Dollard S.C., Cannon M.J. Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004. Clin Infect Dis 2010, 50:1439-1447.
46. Murph J.R., Baron J.C., Brown C.K., Ebelhack C.L., Bale J.F. The occupational risk of cytomegalovirus infection among day-care providers. JAMA 1991, 265:603-608.
47. Adler S.P., Finney J.W., Manganello A.M., Best A.M. Prevention of child-to-mother transmission of cytomegalovirus among pregnant women. J Pediatr 2004, 145:485-491.
48. Jackson L.A., Stewart L.K., Solomon S.L., Boase J., Alexander E.R., Heath J.L., et al. Risk of infection with hepatitis A, B or C, cytomegalovirus, varicella or measles among child care providers. Pediatr Infect Dis J 1996, 15:584-589.
49. Vauloup-Fellous C., Picone O., Cordier A.M., Parent-du-Châtelet I., Senat M.V., Frydman R., et al. Does hygiene counseling have an impact on the rate of CMV infection during pregnancy? Result of a 3-year prospective study in a French hospital. J Clin Virol 2009, 465:S49-S53.
50. Hoffmann K., Heidemann C., Weikert C., Schulze M.B., Boeing H. Estimating the proportion of disease due to classes of sufficient causes. Am J Epidemiol 2006, 163:76-83.
51. Vanderweele T.J. Attributable fractions for sufficient cause interactions. Int J Biostat 2010, 6(Iss. 2). Art. 5.